JG
RVMD icon

Jain Global’s Revolution Medicines RVMD Stock Holding History

Jain Global’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Buy
+11,400
New +$1.67M 0.01% 763

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jain Global's RVMD Position: Q2 2026 in Review

Jain Global opened a new position in Revolution Medicines (RVMD) in Q2 2026: 1,676 shares worth $314K. The stake represents ﹤0.01% of the portfolio and ranks #1368 among its holdings. This is a return to the name: Jain Global previously reported a position in RVMD as recently as Q2 2025.

Jain Global first reported a position in RVMD in Q1 2025 and has held it in 3 quarters since. The position peaked at $4.46M in Q2 2025. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Jain Global held 1,676 shares of Revolution Medicines worth $314K as of Q2 2026.
  • Revolution Medicines was a new Jain Global position in Q2 2026.
  • Revolution Medicines made up ﹤0.01% of Jain Global's portfolio in Q2 2026, its #1368 holding.
  • Jain Global first reported a position in Revolution Medicines in Q1 2025 and has held it in 3 quarters since.
  • Jain Global's Revolution Medicines position peaked at $4.46M in Q2 2025.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Jain Global's 13F filing for Q2 2026, filed 14 Aug 2026.